Loading...
XJPX
6678
Market cap88mUSD
Jun 16, Last price  
1,859.00JPY
1D
0.22%
1Q
2.99%
Jan 2017
-5.35%
IPO
68.49%
Name

Techno Medica Co Ltd

Chart & Performance

D1W1MN
XJPX:6678 chart
P/E
9.55
P/S
1.25
EPS
194.58
Div Yield, %
3.66%
Shrs. gr., 5y
-1.88%
Rev. gr., 5y
1.96%
Revenues
10.28b
+9.78%
6,668,551,0006,730,946,0007,055,186,0007,559,455,0007,980,933,0008,151,194,0009,000,060,0009,519,640,0009,032,422,0008,457,238,0008,654,247,0009,332,420,0009,810,534,0009,040,115,0009,699,077,0009,367,586,00010,283,851,000
Net income
1.35b
+17.15%
873,233,000846,212,000784,077,000933,526,0001,074,418,0001,243,745,0001,355,064,0001,486,533,0001,197,035,000458,128,0001,308,516,0001,098,100,0001,000,452,0001,153,260,0001,281,384,0001,150,733,0001,348,130,000
CFO
1.14b
+28.79%
543,613,000124,427,000683,560,000744,796,000732,904,0001,282,503,0001,051,651,0001,729,325,0001,075,474,000695,462,0001,517,084,000704,255,0001,269,281,000825,412,0002,062,978,000887,240,0001,142,703,000
Dividend
Mar 28, 20250 JPY/sh

Profile

Techno Medica Co., Ltd. engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan. The company offers test tube preparation, automatic urine aliquot, RFID specimen management, and RFID blood transfusion management, as well as blood gas, electrolyte, Erythrocyte Sedimentation Rate, nutrient, sugar and acid, and urine chemistry analyzers; electronic medical charts and pre-analytical instruments; and consumables and after sales services. Techno Medica Co., Ltd. was incorporated in 1987 and is headquartered in Yokohama, Japan.
URL
https://www.technomedica.co.jp/t01/
IPO date
Sep 17, 2003
Employees
225
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
10,283,851
9.78%
9,367,586
-3.42%
Cost of revenue
5,902,480
5,355,292
Unusual Expense (Income)
NOPBT
4,381,371
4,012,294
NOPBT Margin
42.60%
42.83%
Operating Taxes
512,488
515,040
Tax Rate
11.70%
12.84%
NOPAT
3,868,883
3,497,254
Net income
1,348,130
17.15%
1,150,733
-10.20%
Dividends
(508,414)
(505,088)
Dividend yield
3.68%
3.16%
Proceeds from repurchase of equity
(3,697,501)
BB yield
26.80%
Debt
Debt current
(98,769)
Long-term debt
Deferred revenue
Other long-term liabilities
255,887
245,875
Net debt
(8,586,362)
(12,059,058)
Cash flow
Cash from operating activities
1,142,703
887,240
CAPEX
(102,225)
(138,738)
Cash from investing activities
(100,716)
(155,370)
Cash from financing activities
(4,205,916)
(505,088)
FCF
3,461,812
3,194,260
Balance
Cash
8,586,360
11,750,289
Long term investments
2
210,000
Excess cash
8,072,169
11,491,910
Stockholders' equity
8,001,444
15,979,206
Invested Capital
6,073,033
4,793,364
ROIC
71.21%
79.00%
ROCE
31.13%
24.64%
EV
Common stock shares outstanding
7,795
8,440
Price
1,770.00
-6.60%
1,895.00
21.40%
Market cap
13,796,911
-13.73%
15,993,461
20.62%
EV
5,210,549
3,934,403
EBITDA
4,494,353
4,120,350
EV/EBITDA
1.16
0.95
Interest
Interest/NOPBT